Eloxx Pharmaceuticals, Inc (ELOX)

Etorro trading 970x250
Eloxx Pharmaceuticals, Inc (ELOX) Logo

About Eloxx Pharmaceuticals, Inc

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribonucleic acid modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial that focuses on the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company was incorporated in 2013 and is headquartered in Waltham, Massachusetts. Address: 950 Winter Street, Waltham, MA, United States, 02451

Eloxx Pharmaceuticals, Inc News and around…

Latest news about Eloxx Pharmaceuticals, Inc (ELOX) common stock and company :

11 Best Penny Stocks To Buy According To Hedge Funds
15 Oct, 2021 Yahoo! Finance

In this article, we discuss the 11 best penny stocks to buy according to hedge funds. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Penny Stocks To Buy According To Hedge Funds. Hedge funds do not normally invest in penny stocks, primarily because of the risk […]

Is Eloxx Pharmaceuticals (NASDAQ:ELOX) Weighed On By Its Debt Load?
10 Oct, 2021 Yahoo! Finance

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

12 Health Care Stocks Moving In Friday's Pre-Market Session
08 Oct, 2021 FinancialContent

Gainers ChemoCentryx (NASDAQ:CCXI) shares rose 77.65% to $34.82 during Friday's pre-market session. The ...

18 Stocks Moving in Friday's Pre-Market Session
08 Oct, 2021 FinancialContent

Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) rose 25.5% to $14.41 in pre-market trading after the company, in collaboration ...

Eloxx Pharmaceuticals to Host Investor and Analyst Call and Webcast on Cystic Fibrosis Programs
07 Oct, 2021 Yahoo! Finance

Globally renowned CF Expert, Dr. Eitan Kerem will provide key insights Data from ongoing Phase 2 trials in CF expected in 4Q 2021 WATERTOWN, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), today announced that it will host an Investor and Analyst call and webcast on Tuesday, October 12, 2021. The event will include an update on the company’s cystic fibrosis programs and will feature Dr. Eitan Kerem, a globally renowned CF expert. The event is intended to prov

Eloxx Pharmaceuticals Secures Debt Facility of Up to $30 Million from Hercules Capital
05 Oct, 2021 Yahoo! Finance

WATERTOWN, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), today announced that the company has entered into a debt facility of up to $30.0 million with Hercules Capital, Inc. (NYSE: HTGC), a specialty financing lender for life science and technology companies. Eloxx has drawn the initial tranche of $12.5 million and used the proceeds to repay in full amounts outstanding under the Company’s existing debt facility. The remaining funds under the new facility wi

Why Pharmaceutical Companies in Ovarian Cancer Drugs Market are Betting Big on R&D
17 Sep, 2021 FinancialContent
12 Health Care Stocks Moving In Thursday's Intraday Session
09 Sep, 2021 FinancialContent

Gainers Impel NeuroPharma (NASDAQ:IMPL) shares increased by 22.16% to $20.29 during Thursday's regular session. ...

Eloxx Stock Moves Higher On Fast Track Tag For Cystic Fibrosis Candidate
09 Sep, 2021 FinancialContent

TheFDA has granted Fast Track designationEloxx Pharmaceuticals Inc's(NASDAQ: ELOX) ELX-02, a drug candidate ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
09 Sep, 2021 FinancialContent

Gainers Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The ...

Eloxx Pharmaceuticals Announces Fast Track Designation for ELX-02 for the Treatment of Cystic Fibrosis Patients with Nonsense Mutations
09 Sep, 2021 FinancialContent
Eloxx Pharmaceuticals Appoints Chief Medical Officer
08 Sep, 2021 FinancialContent

Ali Hariri, M.D. to Lead Clinical Development Efforts for Company Pipeline

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
18 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
17 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Eloxx Pharmaceuticals Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update
16 Aug, 2021 FinancialContent
12 Health Care Stocks Moving In Wednesday's After-Market Session
28 Jul, 2021 FinancialContent

Gainers Corvus Pharmaceuticals (NASDAQ:CRVS) stock rose 11.46% to $2.43 during Wednesday's after-market session. Trading volume for ...

Hemogenyx Pharmaceuticals PLC Announces Appointment of Business Advisor & Board Observer
26 Jul, 2021 FinancialContent
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
20 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Here's What Eloxx Pharmaceuticals, Inc.'s (NASDAQ:ELOX) Shareholder Ownership Structure Looks Like
12 Jul, 2021 Yahoo! Finance

A look at the shareholders of Eloxx Pharmaceuticals, Inc. ( NASDAQ:ELOX ) can tell us which group is most powerful...

Are These Hot Penny Stocks Worth Buying Right Now? 7 For Your List
09 Jul, 2021 FinancialContent
12 Health Care Stocks Moving In Wednesday's Intraday Session
07 Jul, 2021 FinancialContent

Gainers Opiant Pharmaceuticals (NASDAQ:OPNT) shares increased by 28.31% to $17.05 during Wednesday's regular session. Trading volume ...

Eloxx Pharma Sees Data Readout From First Four Arms Of Cystic Fibrosis Study By End Of 2021
07 Jul, 2021 FinancialContent

Eloxx Pharmaceuticals Inc(NASDAQ: ELOX)provided an enrollment updatefor the ongoing Phase 2 trial of ELX-02 to ...

Eloxx Pharmaceuticals Provides Enrollment Update for Ongoing Phase 2 Clinical Studies for Cystic Fibrosis
06 Jul, 2021 FinancialContent

Data Readout for First Four Treatment Arms Expected in the Fourth Quarter of 2021

7 Reddit Penny Stocks to Watch For the Long Weekend
01 Jul, 2021 FinancialContent
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2021
30 Jun, 2021 FinancialContent

Upgrades For Taiwan Semiconductor Manufacturing Co Ltd (NYSE:TSM), Susquehanna upgraded the previous rating of Negative to Neutral. For ...

12 Health Care Stocks Moving In Tuesday's After-Market Session
29 Jun, 2021 FinancialContent

Gainers Brickell Biotech (NASDAQ:BBI) stock increased by 7.52% to $1.0 during Tuesday's after-market session. Brickell Biotech's ...

44 Biggest Movers From Yesterday
16 Jun, 2021 FinancialContent

Gainers Alzamend Neuro, Inc. (NASDAQ: ALZN) shares jumped 170% to close at $13.50 on Tuesday after the company priced its IPO at ...

3 Biotech Penny Stocks on Robinhood With Big News
15 Jun, 2021 FinancialContent
34 Stocks Moving In Tuesday's Mid-Day Session
15 Jun, 2021 FinancialContent

Gainers HMG/Courtland Properties, Inc. (NYSE: HMG) shares surged 133% to $27.80. Alfi, Inc. (NASDAQ: ALF) shares jumped 82.1% to ...

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
15 Jun, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Eloxx Pharmaceuticals, Inc (ELOX) is a NASDAQ Common Stock listed in , ,

970x250